Original Article
Evaluation of interim modifications for extended dosing intervals of durvalumab for locally advanced unresectable stage III non-small cell lung cancer during the COVID-19 pandemic
Annals of Cancer Epidemiology
2025;
9:
3
(30 May 2025)
Original Article
Development of a composite score to assess colorectal cancer risk based on both genetic and environmental factors
Annals of Cancer Epidemiology
2025;
9:
2
(30 May 2025)